Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
05/05/2010 | CN101700338A Traditional Chinese medicine for treating asthma |
05/05/2010 | CN101700329A Traditional Chinese medicine for treating wind-heat rhinitis |
05/05/2010 | CN101700307A Traditional Chinese medicine for curing chronic pharyngolaryngitis |
05/05/2010 | CN101700293A Traditional Chinese medicine for curing capillary bronchitis |
05/05/2010 | CN101700282A Traditional Chinese medicine for treating wind-cold rhinitis |
05/05/2010 | CN101700281A Preparation method of mixture medicine of honeysuckle, forsythia and scutellaria baicalensis |
05/05/2010 | CN101700280A Traditional Chinese medicine for treating allergic rhinitis |
05/05/2010 | CN101700279A Traditional Chinese medicine for treating children asthmatic brouchitis |
05/05/2010 | CN101700267A Detection method of persimmon leaf quality |
05/05/2010 | CN101700266A Saussurea involucrate nano particles and preparation method and application thereof |
05/05/2010 | CN101700262A Quality control method of andrographis paniculata dropping pills |
05/05/2010 | CN101700247A Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s) |
05/04/2010 | US7709669 Aspirin-triggered lipid mediators |
05/04/2010 | US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
05/04/2010 | US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis |
05/04/2010 | US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents |
05/04/2010 | US7709500 Chemical compounds |
05/04/2010 | US7709489 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2-a]quinoline-2-carbonyl)-4-methylpiperazine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives |
05/04/2010 | US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
05/04/2010 | US7709461 Administering an aerosol of dry polysaccharide such as heparin of given particle size diameter |
05/04/2010 | US7709460 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
05/04/2010 | US7709214 Using antibody specific blocking agents to treat and prevent infection, cell proliferative and immunosuppressive disorders |
05/04/2010 | US7709020 Implantable device comprising phosphorus-containing macrolides |
05/04/2010 | US7708987 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR; antitumor agents |
05/04/2010 | CA2440419C Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
05/04/2010 | CA2427608C Condensed pyradizindione derivatives as pde inhibitors |
05/04/2010 | CA2418395C Protein induced by homogeneous blood transfusion and dna encoding the same |
05/04/2010 | CA2352484C Pressurised metered dose inhalers (mdi) |
04/29/2010 | WO2010048573A1 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide |
04/29/2010 | WO2010048564A1 Modulators of cystic fibrosis transmembrane conductance regulator |
04/29/2010 | WO2010048384A2 Arformoterol and tiotropium compositions and methods for use |
04/29/2010 | WO2010048087A2 Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone |
04/29/2010 | WO2010047928A2 Methods and compositions for treatment of fibrosis |
04/29/2010 | WO2010047361A1 Pharmaceutical composition improved in absorption through intestinal tract |
04/29/2010 | WO2010047127A1 PHENANTHROINDOLIZIDINE COMPOUND AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT |
04/29/2010 | WO2010047126A1 PHENANTHROINDOLIZIDINE DERIVATIVE AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT |
04/29/2010 | WO2010046791A1 Phosphodiestarase inhibitors |
04/29/2010 | WO2010003120A3 Antagonists of prostaglandin d2 receptors |
04/29/2010 | WO2009143483A3 PsrP IS A PROTECTIVE ANTIGEN AGAINST PNEUMOCOCCAL INFECTION |
04/29/2010 | US20100105915 Chemokine receptor binding heterocyclic compounds |
04/29/2010 | US20100105896 Pharmaceutical compounds |
04/29/2010 | US20100105723 5-PHENYL-6-PYRIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZO[4,5-b]PYRIDIN-2-ONE DERIVATIVES USEFUL AS A2B ADENOSINE RECEPTOR ANTAGONISTS |
04/29/2010 | US20100105704 7-(3',4'-Dialkoxyphenyl)-[1,2,4]-Triazolo[1,5-A]Pyrimidine Compounds, Process for Preparing Thereof, and Pharmaceutical Composition for Treating or Preventing Asthma, Chronic Obstructive Pulmonary Disease, Arthritis, Atopic Dermatitis, Tumor and Degenerative Brain Diseases Comprising the Same |
04/29/2010 | US20100105701 Gyrase inhibitors and uses thereof |
04/29/2010 | US20100105689 Novel 1,4- and 1,5-diarylsubstituted 1,2,3-triazoles useful as potassium channel modulators |
04/29/2010 | US20100105685 S-Nitrosothiol Compounds and Related Derivatives |
04/29/2010 | US20100105681 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
04/29/2010 | US20100105660 Organic compounds75074 |
04/29/2010 | US20100105611 Method of treating respiratory disorders |
04/29/2010 | US20100105603 Methods and Preparations For Curing Clinically Ill Patients |
04/29/2010 | US20100104665 Methods and Apparatus for Treating Rhinitis |
04/29/2010 | US20100104632 Drug Having Regulatory Cell Ligand Contained in Liposome |
04/29/2010 | US20100104594 Pathogen for bacterial poultry disease |
04/29/2010 | US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
04/29/2010 | US20100104516 Use of flagellin to prevent and treat gram negative bacterial infection |
04/29/2010 | CA2742042A1 Modulators of cystic fibrosis transmembrane conductance regulator |
04/29/2010 | CA2741718A1 Modulators of cystic fibrosis transmembrane conductance regulator |
04/29/2010 | CA2741178A1 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide |
04/29/2010 | CA2741078A1 Arformoterol and tiotropium compositions and methods for use |
04/29/2010 | CA2740810A1 Phenanthroindolizidine compound and nf.kappa.b inhibitor containing same as active ingredient |
04/29/2010 | CA2740807A1 Phenanthroindolizidine derivative and nf.kappa.b inhibitor containing same as active ingredient |
04/29/2010 | CA2739882A1 Pharmaceutical composition improving intestinal absorption |
04/29/2010 | CA2735956A1 Phosphodiestarase inhibitors |
04/28/2010 | EP2179730A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
04/28/2010 | EP2179039A2 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles |
04/28/2010 | EP2178881A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
04/28/2010 | EP2178549A1 Antimicrobial peptide, compositions , and methods of use |
04/28/2010 | EP2178534A1 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment |
04/28/2010 | EP1590321B1 Aryl alkyl carbamate derivatives production and use thereof in therapy |
04/28/2010 | EP1480615B1 Formoterol superfine formulation |
04/28/2010 | EP1420785B1 Substituted indeno [1,2-c]isoquinoline derivatives and methods of use thereof |
04/28/2010 | EP1363640B1 Nucleic acid derivatives |
04/28/2010 | CN1904041B Human recombination phospholipase D2, its preparation method and application in preparation medicine |
04/28/2010 | CN1875020B Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same |
04/28/2010 | CN1733125B Pharmaceutical purpose of effective parts of immature Bitter orange or trifoliate-orange root-bark |
04/28/2010 | CN1728988B Powdered medicaments containing a tiotropium salt and salmeterol xinafoate |
04/28/2010 | CN1678333B Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease |
04/28/2010 | CN1658877B Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
04/28/2010 | CN1555417B Paramyxovirus vector for gene transfer to the cardiovascular system |
04/28/2010 | CN1468307B Anti-dual integrin antibodies, compositions, methods and uses |
04/28/2010 | CN101698060A Medicament for treating chronic pharyngitis |
04/28/2010 | CN101698054A Preparation for treating sore throat |
04/28/2010 | CN101698046A Lozenge for diminishing inflammation and clearing pharynx |
04/28/2010 | CN101698030A Medicine for treating chronic nasosinusitis and preparation method thereof |
04/28/2010 | CN101698024A Traditional Chinese medicine for treating respiratory diseases and promoting growth for swine and preparation method thereof |
04/28/2010 | CN101698023A Chinese herbal medicine formula for treating asthma |
04/28/2010 | CN101698012A Throat clearing and moistening health-care tea for preventing and treating chronic pharyngitis |
04/28/2010 | CN101698004A Traditional Chinese medicine composite for treating asthma |
04/28/2010 | CN101698000A Traditional Chinese medicine for treating allergic rhinitis |
04/28/2010 | CN101697998A Zhenhuang tablet for treating sore throat and ulcer and sore furuncle and preparation method thereof |
04/28/2010 | CN101697996A Chinese herbal medicinal composition for externally treating allergic rhinitis |
04/28/2010 | CN101697965A Inhalation capsules |
04/27/2010 | USRE41287 Cyclic agonists and antagonists of C5A receptors and G Protein-coupled receptors |
04/27/2010 | US7705195 Screening method |
04/27/2010 | US7705050 Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophils |
04/27/2010 | US7705015 Substituted pyrroline kinase inhibitors |
04/27/2010 | US7704999 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
04/27/2010 | US7704975 Modafinil compound and cyclodextrin mixtures |
04/27/2010 | US7704969 Transfection complexes |
04/27/2010 | US7704960 Administering Erythromycin A having had the cladinose moiety in the 3-position removed by acidolysis to produce an antiinflammatory agent having no antibiotic properties; chronic respiratory system disorders; cytokine suppressive antiinflammatory drugs; antiarthritic agents; antiischemic agents |